You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company said that it has priced a public offering of 2,651,108 shares of its common stock at $32 per share.
In Q2 the firm filed for FDA Emergency Use Authorization for its saliva-based Advanta Sx SARS-CoV-2 RT-PCR assay as it continued its pivot to COVID-19 markets.
The company posted Q2 revenues of $13.1 million, down from $13.5 million in Q2 2019 but above the consensus Wall Street estimate of $11.8 million.
Fluidigm's Helios mass cytometer and Hyperion imaging system will be bundled with De Novo's FCS Express 7 Flow software for suspension data analysis.
The company reported Q2 revenues of $424.6 million, down from $490.2 million in Q2 2019 but beating the consensus Wall Street estimate of $390.9 million.
SomaLogic will analyze more than 40,000 samples, including from Amgen clinical trials, using its SomaScan platform, which measures up to 5,000 proteins.
The partnership will provide Chinese customers access to the company's IsoLight platform, which enables multiplexed immunoassays at the single-cell level.
The company posted Q2 revenues of $520.0 million, down 13 percent from $599.2 million in Q2 2019, but above analysts' average estimate of $496.9 million.
The firm uses a miniaturized, bead-based-ELISA format to multiplex hundreds to thousands of immunoassays rapidly and without antibody cross-reactivity.
Called ProteoGraph, the system uses nanoparticles to bind proteins in biological samples and could enable deeper and faster proteomic profiling, the firm said.
The company said that the better-than-expected projections were driven mainly by stronger demand for its life science products.
The firm said that it plans to use the funds to expand its R&D work and to prepare for the 2021 commercial launch of its proteomics system, called Proteograph.
The company has developed a microscopy system that allows imaging of a full pathology slide in 21 channels with a single staining process and a rapid turnaround time.
Bruker's system has seen strong uptake among proteomics researchers, but its ability to generate large amounts of complex data has led to analysis challenges.
The firm's predicted Q2 revenues of $517 million to $523 million beat expectations as former MilliporeSigma CEO Udit Batra becomes president and CEO.
Researchers developed a highly multiplexed screen to quantify the co-expression of 351 molecules on the surfaces of millions of human B cells.
Three research teams profiled proteomic, genomic, and other features in lung adenocarcinomas in Asia and other parts of the world, including cases in never-smokers.
Twist will give Takeda access to its phage display libraries to help Takeda discover and validate antibodies needed for the development of new biologics.
The deal makes WuXi NextCode the exclusive provider of Olink's proteomics products in China, which the company will offer on a fee-for-service basis.
Abcam will develop custom protein-based reagents for targets identified by researchers funded by Cancer Research UK.
The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.
The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.
Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.
In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.